Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05212714 · ClinicalTrials.gov registry record · NA

taVNS to Reduce PTSD Symptoms in WTC Responders

A NA study of Stress Disorders, Post-Traumatic, sponsored by Northwell Health.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05212714 is a NA study of Stress Disorders, Post-Traumatic that has completed, run by Northwell Health. The registered enrollment target is 30 participants, below the 155-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05212714, a NA study of Stress Disorders, Post-Traumatic, has completed, sponsored by Northwell Health.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study seeks to conduct a randomized, double-blind pilot study, to determine whether the Transcutaneous Auricular Vagus Nerve Stimulation and study procedure are feasible and acceptable for use with World Trade Center responders with Post Traumatic Stress Disorder.

Interventions

  • DEVICE taVNS

Study Locations (1)

New York

  • Feinstein Institutes for Medical Research - Manhasset

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-03-31
Est. Completion 2024-02-15
Phase NA

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT05212714

The ClinicalTrials.gov registry entry for NCT05212714 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 155-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (81% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 1 intervention - of which taVNS is the first listed.

NCT05212714 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05212714 about?

NCT05212714 is a clinical study titled "taVNS to Reduce PTSD Symptoms in WTC Responders". This study seeks to conduct a randomized, double-blind pilot study, to determine whether the Transcutaneous Auricular Vagus Nerve Stimulation and study procedure are feasible and acceptable for use with World Trade Center responders with Post Traumatic Stress Disorder.

What is the current status of trial NCT05212714?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-03-31. Estimated completion is 2024-02-15.

What conditions does trial NCT05212714 study?

This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.

What interventions are being tested in trial NCT05212714?

The interventions under investigation include: taVNS (DEVICE).

Who is sponsoring clinical trial NCT05212714?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05212714 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress Disorders, Post-Traumatic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.